BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Open Medical Atlas//cardio//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cardiovascular Atlas: upcoming events
X-WR-CALDESC:Expected events as of 2026-10-15\, from the sources the atlas 
 cites. General information from published sources\, not medical advice\, a
 nd not reviewed by clinicians. Check the cited source before relying on an
 ything here.
BEGIN:VEVENT
UID:cardio:orion-4#primary_completion_date@cardio.openmedicalatlas.org
DTSTAMP:20261015T163149Z
DTSTART;VALUE=DATE:20261001
DTEND;VALUE=DATE:20261002
SUMMARY:Primary completion (expected sometime in October 2026): ORION-4 (in
 clisiran outcome trial)
DESCRIPTION:Expected sometime in October 2026\; the calendar shows the firs
 t day of that period.\nDate listed by U.S. National Library of Medicine (C
 linicalTrials.gov)\, retrieved on 2026-10-14.\nSource: A Randomized Trial 
 Assessing the Effects of Inclisiran on Clinical Outcomes Among People With
  Cardiovascular Disease https://clinicaltrials.gov/study/NCT03705234\nAn e
 xpected date is a statement by the source\, not a result\, and it can move
 .\nGeneral information from published sources\, not medical advice\, and n
 ot reviewed by clinicians. Check the cited source before relying on anythi
 ng here.
URL:https://cardio.openmedicalatlas.org/studies/orion-4/
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cardio:triluminate#completion_date@cardio.openmedicalatlas.org
DTSTAMP:20261015T163149Z
DTSTART;VALUE=DATE:20290401
DTEND;VALUE=DATE:20290402
SUMMARY:Study completion (expected sometime in April 2029): TRILUMINATE Piv
 otal trial
DESCRIPTION:Expected sometime in April 2029\; the calendar shows the first 
 day of that period.\nDate listed by U.S. National Library of Medicine (Cli
 nicalTrials.gov)\, retrieved on 2026-10-14.\nSource: TRILUMINATE Pivotal T
 rial https://clinicaltrials.gov/study/NCT03904147\nAn expected date is a s
 tatement by the source\, not a result\, and it can move.\nGeneral informat
 ion from published sources\, not medical advice\, and not reviewed by clin
 icians. Check the cited source before relying on anything here.
URL:https://cardio.openmedicalatlas.org/studies/triluminate/
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cardio:evolut-low-risk#completion_date@cardio.openmedicalatlas.org
DTSTAMP:20261015T163149Z
DTSTART;VALUE=DATE:20290601
DTEND;VALUE=DATE:20290602
SUMMARY:Study completion (expected sometime in June 2029): Evolut Low Risk 
 trial
DESCRIPTION:Expected sometime in June 2029\; the calendar shows the first d
 ay of that period.\nDate listed by U.S. National Library of Medicine (Clin
 icalTrials.gov)\, retrieved on 2026-10-14.\nSource: Medtronic Evolut Trans
 catheter Aortic Valve Replacement in Low Risk Patients https://clinicaltri
 als.gov/study/NCT02701283\nAn expected date is a statement by the source\,
  not a result\, and it can move.\nGeneral information from published sourc
 es\, not medical advice\, and not reviewed by clinicians. Check the cited 
 source before relying on anything here.
URL:https://cardio.openmedicalatlas.org/studies/evolut-low-risk/
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cardio:partner-3#completion_date@cardio.openmedicalatlas.org
DTSTAMP:20261015T163149Z
DTSTART;VALUE=DATE:20291201
DTEND;VALUE=DATE:20291202
SUMMARY:Study completion (expected sometime in December 2029): PARTNER 3 tr
 ial
DESCRIPTION:Expected sometime in December 2029\; the calendar shows the fir
 st day of that period.\nDate listed by U.S. National Library of Medicine (
 ClinicalTrials.gov)\, retrieved on 2026-10-14.\nSource: PARTNER 3 Trial: S
 afety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low R
 isk Patients With Aortic Stenosis https://clinicaltrials.gov/study/NCT0267
 5114\nAn expected date is a statement by the source\, not a result\, and i
 t can move.\nGeneral information from published sources\, not medical advi
 ce\, and not reviewed by clinicians. Check the cited source before relying
  on anything here.
URL:https://cardio.openmedicalatlas.org/studies/partner-3/
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cardio:early-tavr#completion_date@cardio.openmedicalatlas.org
DTSTAMP:20261015T163149Z
DTSTART;VALUE=DATE:20320301
DTEND;VALUE=DATE:20320302
SUMMARY:Study completion (expected sometime in March 2032): EARLY TAVR
DESCRIPTION:Expected sometime in March 2032\; the calendar shows the first 
 day of that period.\nDate listed by U.S. National Library of Medicine (Cli
 nicalTrials.gov)\, retrieved on 2026-10-14.\nSource: EARLY TAVR: Evaluatio
 n of TAVR Compared to Surveillance for Patients With Asymptomatic Severe A
 ortic Stenosis https://clinicaltrials.gov/study/NCT03042104\nAn expected d
 ate is a statement by the source\, not a result\, and it can move.\nGenera
 l information from published sources\, not medical advice\, and not review
 ed by clinicians. Check the cited source before relying on anything here.
URL:https://cardio.openmedicalatlas.org/studies/early-tavr/
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:cardio:orion-4#completion_date@cardio.openmedicalatlas.org
DTSTAMP:20261015T163149Z
DTSTART;VALUE=DATE:20491201
DTEND;VALUE=DATE:20491202
SUMMARY:Study completion (expected sometime in December 2049): ORION-4 (inc
 lisiran outcome trial)
DESCRIPTION:Expected sometime in December 2049\; the calendar shows the fir
 st day of that period.\nDate listed by U.S. National Library of Medicine (
 ClinicalTrials.gov)\, retrieved on 2026-10-14.\nSource: A Randomized Trial
  Assessing the Effects of Inclisiran on Clinical Outcomes Among People Wit
 h Cardiovascular Disease https://clinicaltrials.gov/study/NCT03705234\nAn 
 expected date is a statement by the source\, not a result\, and it can mov
 e.\nGeneral information from published sources\, not medical advice\, and 
 not reviewed by clinicians. Check the cited source before relying on anyth
 ing here.
URL:https://cardio.openmedicalatlas.org/studies/orion-4/
STATUS:TENTATIVE
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR